<p>Preclinical data with APG777 demonstrate the potential for significantly improved dosing over standard of care, including the potential for every two- or three-month dosing Initial subcutaneo
<p>HOUSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced its 2024 capital expenditure and turnaround outlay guidance with a rang
<p>Businesses across all industries face an increasing burden of regulatory compliance in today's fast expanding digital landscape. The complexity and dynamic nature of regulatory regimes p
Leave a Comment